202 related articles for article (PubMed ID: 20211302)
1. Relationships between emerging measures of heart failure processes of care and clinical outcomes.
Hernandez AF; Hammill BG; Peterson ED; Yancy CW; Schulman KA; Curtis LH; Fonarow GC
Am Heart J; 2010 Mar; 159(3):406-13. PubMed ID: 20211302
[TBL] [Abstract][Full Text] [Related]
2. Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.
Lam PH; Packer M; Gill GS; Wu WC; Levy WC; Zile MR; Brar V; Arundel C; Cheng Y; Singh SN; Allman RM; Fonarow GC; Ahmed A
Am J Med; 2020 Oct; 133(10):1187-1194. PubMed ID: 32272101
[TBL] [Abstract][Full Text] [Related]
3. Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy C; Young JB;
Am Heart J; 2007 Jan; 153(1):82.e1-11. PubMed ID: 17174643
[TBL] [Abstract][Full Text] [Related]
4. Outcomes associated with warfarin use in older patients with heart failure and atrial fibrillation and a cardiovascular implantable electronic device: findings from the ADHERE registry linked to Medicare claims.
Hess PL; Greiner MA; Fonarow GC; Klaskala W; Mills RM; Setoguchi S; Al-Khatib SM; Hernandez AF; Curtis LH
Clin Cardiol; 2012 Nov; 35(11):649-57. PubMed ID: 23070696
[TBL] [Abstract][Full Text] [Related]
5. Postdischarge international normalized ratio testing and long-term clinical outcomes of patients with heart failure receiving warfarin: findings from the ADHERE registry linked to Medicare claims.
Qualls LG; Greiner MA; Eapen ZJ; Fonarow GC; Mills RM; Klaskala W; Hernandez AF; Curtis LH
Clin Cardiol; 2013 Dec; 36(12):757-65. PubMed ID: 24114926
[TBL] [Abstract][Full Text] [Related]
6. Associations between aldosterone antagonist therapy and risks of mortality and readmission among patients with heart failure and reduced ejection fraction.
Hernandez AF; Mi X; Hammill BG; Hammill SC; Heidenreich PA; Masoudi FA; Qualls LG; Peterson ED; Fonarow GC; Curtis LH
JAMA; 2012 Nov; 308(20):2097-107. PubMed ID: 23188026
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Adherence to Guideline for Heart Failure with Reduced Ejection Fraction in Heart Failure with Preserved Ejection Fraction and with or without Atrial Fibrillation.
Ahn MS; Yoo BS; Son JW; Park YJ; Lee HY; Jeon ES; Kang SM; Choi DJ; Kim KH; Cho MC; Kim SY; Kang DR; Go TH
J Korean Med Sci; 2021 Oct; 36(40):e252. PubMed ID: 34664798
[TBL] [Abstract][Full Text] [Related]
8. Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry.
Hernandez AF; Hammill BG; O'Connor CM; Schulman KA; Curtis LH; Fonarow GC
J Am Coll Cardiol; 2009 Jan; 53(2):184-92. PubMed ID: 19130987
[TBL] [Abstract][Full Text] [Related]
9. Beta-blocker Use and 30-day All-cause Readmission in Medicare Beneficiaries with Systolic Heart Failure.
Bhatia V; Bajaj NS; Sanam K; Hashim T; Morgan CJ; Prabhu SD; Fonarow GC; Deedwania P; Butler J; Carson P; Love TE; Kheirbek R; Aronow WS; Anker SD; Waagstein F; Fletcher R; Allman RM; Ahmed A
Am J Med; 2015 Jul; 128(7):715-21. PubMed ID: 25554369
[TBL] [Abstract][Full Text] [Related]
10. Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.
O'Meara E; Khairy P; Blanchet MC; de Denus S; Pedersen OD; Levesque S; Talajic M; Ducharme A; White M; Racine N; Rouleau JL; Tardif JC; Roy D;
Circ Heart Fail; 2012 Sep; 5(5):586-93. PubMed ID: 22798522
[TBL] [Abstract][Full Text] [Related]
11. Projected Clinical Benefits of Implementation of SGLT-2 Inhibitors Among Medicare Beneficiaries Hospitalized for Heart Failure.
Vaduganathan M; Greene SJ; Zhang S; Solomon N; Chiswell K; Devore AD; Butler J; Heidenreich PA; Huang JC; Kittleson MM; Joynt Maddox KE; Mcdermott JJ; Owens AT; Peterson PN; Solomon SD; Vardeny O; Yancy CW; Fonarow GC
J Card Fail; 2022 Apr; 28(4):554-563. PubMed ID: 34785402
[TBL] [Abstract][Full Text] [Related]
12. Mortality associated with the quality of care of patients hospitalized with congestive heart failure.
Luthi JC; McClellan WM; Fitzgerald D; Krumholz HM; Delaney RJ; Bratzler DW; Elward K; Cangialos CB; Ballar DJ;
Int J Qual Health Care; 2002 Feb; 14(1):15-24. PubMed ID: 11871625
[TBL] [Abstract][Full Text] [Related]
13. Effect of warfarin on survival in patients with concomitant left ventricular systolic dysfunction and pulmonary hypertension: a population cohort study.
Goudie A; Elder D; Deshmukh H; Szwejkowski BR; Lang CC; George J
Eur J Heart Fail; 2015 Jan; 17(1):90-7. PubMed ID: 25427720
[TBL] [Abstract][Full Text] [Related]
14. The importance of heart rate recovery in patients with heart failure or left ventricular systolic dysfunction.
Lipinski MJ; Vetrovec GW; Gorelik D; Froelicher VF
J Card Fail; 2005 Oct; 11(8):624-30. PubMed ID: 16230267
[TBL] [Abstract][Full Text] [Related]
15. Evidence-Based Process Performance Measures and Clinical Outcomes in Patients With Incident Heart Failure With Reduced Ejection Fraction: A Danish Nationwide Cohort Study.
Schjødt I; Johnsen SP; Strömberg A; DeVore AD; Valentin JB; Løgstrup BB
Circ Cardiovasc Qual Outcomes; 2022 Apr; 15(4):e007973. PubMed ID: 35272503
[TBL] [Abstract][Full Text] [Related]
16. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
[TBL] [Abstract][Full Text] [Related]
17. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.
Martin N; Manoharan K; Thomas J; Davies C; Lumbers RT
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012721. PubMed ID: 29952095
[TBL] [Abstract][Full Text] [Related]
18. Characteristics, Outcomes, and Treatment of Heart Failure With Improved Ejection Fraction.
Park CS; Park JJ; Mebazaa A; Oh IY; Park HA; Cho HJ; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
J Am Heart Assoc; 2019 Mar; 8(6):e011077. PubMed ID: 30845873
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Quality of Care for US Veterans With Recent-Onset Heart Failure With Reduced Ejection Fraction.
Sandhu AT; Kohsaka S; Turakhia MP; Lewis EF; Heidenreich PA
JAMA Cardiol; 2022 Feb; 7(2):130-139. PubMed ID: 34757380
[TBL] [Abstract][Full Text] [Related]
20. Associations between atrial fibrillation and early outcomes of patients with heart failure and reduced or preserved ejection fraction.
Eapen ZJ; Greiner MA; Fonarow GC; Yuan Z; Mills RM; Hernandez AF; Curtis LH
Am Heart J; 2014 Mar; 167(3):369-375.e2. PubMed ID: 24576522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
